Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Carlsmed (CARL) EBIT Margin (2024 - 2025)

Carlsmed's EBIT Margin history spans 2 years, with the latest figure at 61.44% for Q4 2025.

  • For Q4 2025, EBIT Margin fell 1152.0% year-over-year to 61.44%; the TTM value through Dec 2025 reached 59.42%, changed N/A, while the annual FY2025 figure was 60.53%, 2827.0% up from the prior year.
  • EBIT Margin reached 61.44% in Q4 2025 per CARL's latest filing, up from 69.11% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 49.93% in Q4 2024 to a low of 118.01% in Q3 2024.